AAAAAA

   
Results: 1-16 |
Results: 16
SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - AN EBMT PHASE-II STUDY
Authors: LEYVRAZ S PEREY L ROSTI G LANGE A PAMPALLONA S PASINI F BOSQUEE L HUMBLET Y MARANGOLO M
Citation: S. Leyvraz et al., SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - AN EBMT PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 406-406
CARBOPLATIN AND PACLITAXEL (TAXOL(R)) FOR NONSMALL CELL LUNG-CANCER [NSCLC], A STANDARD REGIMEN
Authors: PRALONGKOHLER J STUPP R MONNERAT C BAUER J STALDER M PEREY L LEYVRAZ S
Citation: J. Pralongkohler et al., CARBOPLATIN AND PACLITAXEL (TAXOL(R)) FOR NONSMALL CELL LUNG-CANCER [NSCLC], A STANDARD REGIMEN, Annals of oncology, 9, 1998, pp. 420-420
REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND ISLET-CELL CARCINOMA - NOT ANTAGONIST, BUT COMPLEMENTARY TOOLS
Authors: BENHATTAR J PEREY L PETERS R LEYVRAZ S
Citation: J. Benhattar et al., REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND ISLET-CELL CARCINOMA - NOT ANTAGONIST, BUT COMPLEMENTARY TOOLS, Journal of clinical oncology, 16(2), 1998, pp. 806-806
HIGH-DOSE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - FINAL RESULTS OF THE EBMT PHASE-II STUDY
Authors: LEYVRAZ S PEREY L ROSTI G LANGE A PAMPALLONA S PASINI F BOSQUEE L HUMBLET Y MARANGOLO M
Citation: S. Leyvraz et al., HIGH-DOSE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - FINAL RESULTS OF THE EBMT PHASE-II STUDY, Bone marrow transplantation, 21, 1998, pp. 800-800
SUBJECTIVE HEALTH ESTIMATIONS (SHE) IN PATIENTS WITH ADVANCED BREAST-CANCER - AN ADAPTED UTILITY CONCEPT FOR CLINICAL-TRIALS
Authors: HURNY C VANWEGBERG B BACCHI M BERNHARD J THURLIMANN B REAL O PEREY L BONNEFOI H COATES A
Citation: C. Hurny et al., SUBJECTIVE HEALTH ESTIMATIONS (SHE) IN PATIENTS WITH ADVANCED BREAST-CANCER - AN ADAPTED UTILITY CONCEPT FOR CLINICAL-TRIALS, British Journal of Cancer, 77(6), 1998, pp. 985-991
APOPTOTIC REGULATION IN PRIMITIVE HEMATOPOIETIC PRECURSORS
Authors: PETERS R LEYVRAZ S PEREY L
Citation: R. Peters et al., APOPTOTIC REGULATION IN PRIMITIVE HEMATOPOIETIC PRECURSORS, Blood, 92(6), 1998, pp. 2041-2052
COST IDENTIFICATION OF PAV VERSUS ICE TREATMENT IN SCLC
Authors: ROLLIER P PEREY L BAUER J LEYVRAZ S WASSERFALLEN JB
Citation: P. Rollier et al., COST IDENTIFICATION OF PAV VERSUS ICE TREATMENT IN SCLC, European journal of cancer, 33, 1997, pp. 68-68
EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
APOPTOTIC REGULATION OF HEMATOPOIETIC-CELLS DURING EX-VIVO EXPANSION
Authors: PETERS R PEREY L FAES E JAUNIN P LEYVRAZ S
Citation: R. Peters et al., APOPTOTIC REGULATION OF HEMATOPOIETIC-CELLS DURING EX-VIVO EXPANSION, Blood, 90(10), 1997, pp. 1397-1397
ARE CD34-DOSE CHEMOTHERAPY( SUBPOPULATIONS USEFUL PREDICTIVE FACTORS FOR HEMATOPOIETIC RECOVERY AFTER HIGH)
Authors: PEREY L PETERS R PAMPALLONA S SCHNEIDER P LEYVRAZ S
Citation: L. Perey et al., ARE CD34-DOSE CHEMOTHERAPY( SUBPOPULATIONS USEFUL PREDICTIVE FACTORS FOR HEMATOPOIETIC RECOVERY AFTER HIGH), Blood, 88(10), 1996, pp. 3689-3689
APOPTOSIS OF HEMATOPOIETIC PROGENITOR CELLS
Authors: PETERS R PEREY L JANOSSY G PAMPALLONA S LEYVRAZ S
Citation: R. Peters et al., APOPTOSIS OF HEMATOPOIETIC PROGENITOR CELLS, Blood, 88(10), 1996, pp. 174-174
CD34 PROGENITOR CELLS THAT LACK CD38 ANTIGEN EXPRESSION ARE RICH IN CD61 PLATELET-SPECIFIC ANTIGEN
Authors: PETERS R PEREY L LEYVRAZ S
Citation: R. Peters et al., CD34 PROGENITOR CELLS THAT LACK CD38 ANTIGEN EXPRESSION ARE RICH IN CD61 PLATELET-SPECIFIC ANTIGEN, Blood, 88(10), 1996, pp. 1594-1594
EXPRESSION OF THE DF3-P EPITOPE IN HUMAN OVARIAN CARCINOMAS
Authors: ICHIGE K PEREY L VOGEL CA BUCHEGGER F KUFE D
Citation: K. Ichige et al., EXPRESSION OF THE DF3-P EPITOPE IN HUMAN OVARIAN CARCINOMAS, Clinical cancer research, 1(5), 1995, pp. 565-571
HIGH-DOSE SEQUENTIAL CHEMOTHERAPY (ICE) UNDER CIRCULATING PROGENITOR CELLS (CPC) PROTECTION IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA (SCLC) - PRELIMINARY-REPORT ON A MULTICENTRIC STUDY
Authors: LEYVRAZ S LANGE A PEREY L KETTERER N BOSQUEE L ROSTI G PASINI F HAMDAN O HUMBLET Y CETTO GL MARANGOLO M
Citation: S. Leyvraz et al., HIGH-DOSE SEQUENTIAL CHEMOTHERAPY (ICE) UNDER CIRCULATING PROGENITOR CELLS (CPC) PROTECTION IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA (SCLC) - PRELIMINARY-REPORT ON A MULTICENTRIC STUDY, European journal of cancer, 31A, 1995, pp. 90-90
HUMAN CHORIONIC-GONADOTROPIN FOR AID-RELATED KAPOSIS-SARCOMA
Authors: VONOVERBECK J PEREY L ITEN A PECHERE M RUFFIEUX P HIRSCHEL B
Citation: J. Vonoverbeck et al., HUMAN CHORIONIC-GONADOTROPIN FOR AID-RELATED KAPOSIS-SARCOMA, Lancet, 346(8975), 1995, pp. 642-643
INTENSIFICATION OF CHEMOTHERAPY FOR THE TREATMENT OF SOLID TUMORS - FEASIBILITY OF A 3-FOLD INCREASE IN DOSE INTENSITY WITH PERIPHERAL-BLOOD PROGENITOR CELLS AND GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: LEYVRAZ S KETTERER N PEREY L BAUER J VUICHARD P GROB JP SCHNEIDER P VONFLIEDNER V LEJEUNE F BACHMANN F
Citation: S. Leyvraz et al., INTENSIFICATION OF CHEMOTHERAPY FOR THE TREATMENT OF SOLID TUMORS - FEASIBILITY OF A 3-FOLD INCREASE IN DOSE INTENSITY WITH PERIPHERAL-BLOOD PROGENITOR CELLS AND GRANULOCYTE-COLONY-STIMULATING FACTOR, British Journal of Cancer, 72(1), 1995, pp. 178-182
Risultati: 1-16 |